JAK2 and glioblastoma: A mechanistic investigation established 5-AcTMF as an inhibitor of STAT3 activation, likely through blocking JAK2 activation (Figure 2), and further validated the essential role of STAT3 blockage in 5-AcTMF-elicited GBM cell apoptosis and suppression of GBM clonogenicity (Figure 3).